We have detected you are coming from a location outside of Germany.
Wir haben festgestellt, dass Sie von einem Standort außerhalb Deutschlands auf diese Seite gelangt sind.

Please select your preferred language:
Bitte wählen Sie eine der folgenden Sprachoptionen:

Go back

Non-Invasive Prenatal Testing (NIPT) Collaboration Opportunities Now Available

As part of a recent company move to expand its NIPT genetic testing to the international market1, the MGZ - Medical Genetics Center is inviting clinical institutions, diagnostic laboratories, and resellers interested in offering this testing to specific geographic locations to contact the MGZ about possible partnership/distribution opportunities.

The MGZ, in collaboration with praena bayern in Munich, Germany, offers NIPT known as the PraenaTest®/ PrenaTest, based on next-generation sequencing (NGS) technology and listed as one of the top ten NIPT tests in the market today.

NIPT is a safe and reliable non-invasive prenatal test for the determination of common chromosomal aneuploidies such as trisomies 13, 18, and 21, sex chromosome abnormalities, and microdeletion syndromes.

Overview of NIPT at the MGZ

  • NIPT in the hands of human genetic specialists

-  The MGZ ensures the complete and careful implementation of NIPT under specialist medical responsibility.

-  Medical validation of all NIPT results is done by MGZ’s clinical geneticists.

  • Proven experience with NIPT since May, 2016

-  Over 8000 NIPT tests have already been carried out by the MGZ and its associated partners at MGZ’s on-site laboratory in Munich, Germany.

  • High quality testing

-  A very high accuracy in the determination of a high risk of trisomy 21, 18, or 13 in the unborn child.

-  Very high sensitivity. For trisomy 21, this sensitivity is almost 100% (98.7%) 2.

-  Technical validation is performed by MGZ’s scientific team.

  • Several test options available, each based upon next-generation sequencing (NGS) technology. 
  • Analysis available from the 9th week of pregnancy (9+0 p.m) and also in the case of a twin pregnancy. 
  • Short turnaround time (TAT) of 4-6 working days3
  • Test tracking feature for patients

- Patients can follow their sample through the testing process online to see when a sample has arrived and when their test results should be ready

  • Consultations with MGZ’s clinical team

-  Our specialists are available to discuss patient results with requesting physicians, especially in cases of inconspicuous findings or particular clinical cases.

  • Test results available in English and German. 
  • PraenaTest® kits available from MGZ. 

NIPT has been defined as a genetic examination in accordance with the German Genetic Diagnostics Act (GenDG), which means among other things that special training in genetic counseling issues is required from the offering gynecologists.

For those institutions/resellers interested in taking advantage of a growing NIPT market and working together with a reliable, trustworthy provider with both medical and technical expertise, contact us at inquiry@mgz-muenchen.com for more information and details on this collaboration opportunity.

 

Notes:  1. Excludes USA and Canada 2. Reference: https://lifecodexx.com/fuer-aerzte/klinische-studien 3. A longer TAT may be a result of longer shipping times required for international requests.